Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| adipocyte | 9 studies | 25% ± 9% | |
| endothelial cell | 6 studies | 20% ± 3% | |
| epithelial cell | 5 studies | 25% ± 8% | |
| fibroblast | 5 studies | 23% ± 8% | |
| rod bipolar cell | 3 studies | 17% ± 2% | |
| GABAergic neuron | 3 studies | 48% ± 8% | |
| glutamatergic neuron | 3 studies | 53% ± 10% | |
| astrocyte | 3 studies | 19% ± 3% | |
| interneuron | 3 studies | 40% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1483.51 | 1445 / 1445 | 100% | 26.65 | 183 / 183 |
| intestine | 100% | 1637.80 | 966 / 966 | 100% | 27.38 | 526 / 527 |
| stomach | 100% | 1308.95 | 359 / 359 | 100% | 28.54 | 285 / 286 |
| breast | 100% | 2193.51 | 459 / 459 | 100% | 29.95 | 1114 / 1118 |
| lung | 100% | 1592.15 | 577 / 578 | 100% | 20.32 | 1150 / 1155 |
| brain | 99% | 1349.98 | 2618 / 2642 | 100% | 20.61 | 705 / 705 |
| thymus | 100% | 1657.32 | 653 / 653 | 99% | 20.11 | 598 / 605 |
| ovary | 100% | 3591.77 | 180 / 180 | 99% | 16.89 | 425 / 430 |
| bladder | 100% | 1647.14 | 21 / 21 | 98% | 19.00 | 496 / 504 |
| pancreas | 100% | 903.91 | 327 / 328 | 98% | 14.54 | 175 / 178 |
| uterus | 100% | 2228.13 | 170 / 170 | 98% | 22.02 | 448 / 459 |
| adrenal gland | 100% | 2669.44 | 258 / 258 | 97% | 28.37 | 223 / 230 |
| prostate | 100% | 1640.49 | 245 / 245 | 97% | 14.16 | 485 / 502 |
| skin | 100% | 1411.09 | 1808 / 1809 | 94% | 17.52 | 444 / 472 |
| kidney | 100% | 1041.45 | 89 / 89 | 92% | 13.79 | 829 / 901 |
| liver | 100% | 865.63 | 226 / 226 | 86% | 9.57 | 348 / 406 |
| adipose | 100% | 2293.22 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 28.00 | 29 / 29 |
| spleen | 100% | 1363.25 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.68 | 1 / 1 |
| blood vessel | 100% | 1345.40 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 98% | 929.23 | 790 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 15.22 | 44 / 45 |
| heart | 95% | 734.59 | 815 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 75% | 8.92 | 60 / 80 |
| peripheral blood | 57% | 743.00 | 528 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030500 | Biological process | regulation of bone mineralization |
| GO_0010564 | Biological process | regulation of cell cycle process |
| GO_0051726 | Biological process | regulation of cell cycle |
| GO_0005829 | Cellular component | cytosol |
| GO_0031965 | Cellular component | nuclear membrane |
| GO_0140297 | Molecular function | DNA-binding transcription factor binding |
| GO_0019905 | Molecular function | syntaxin binding |
| Gene name | TXLNG |
| Protein name | Gamma-taxilin (Environmental lipopolysaccharide-responding gene protein) (Factor inhibiting ATF4-mediated transcription) (FIAT) (Lipopolysaccharide-specific response protein 5) |
| Synonyms | CXorf15 ELRG LSR5 |
| Description | FUNCTION: May be involved in intracellular vesicle traffic. Inhibits ATF4-mediated transcription, possibly by dimerizing with ATF4 to form inactive dimers that cannot bind DNA. May be involved in regulating bone mass density through an ATF4-dependent pathway. May be involved in cell cycle progression. . |
| Accessions | Q9NUQ3 ENST00000398155.4 [Q9NUQ3-2] ENST00000380122.10 [Q9NUQ3-1] |
